Ager et al. demonstrated that anti-MMP14 mAb DX-2400 alone was able to enhance anti-tumour immunity to impede tumour growth and enhance radiotherapy response in 4T1 nude mouse xenografts and syngeneic E0771 immune-competent models [196]. This evidence concerns the gene MMP14 and neoplasm.